EP Patent

EP1790335A1 — Composition and its use for the manufacture of a medicament for treating, prophylactically treating, preventing cancer and/or infections in the urinary tract

Assigned to Nolabs AB · Expires 2007-05-30 · 19y expired

What this patent protects

A composition is provided that allows for treatment of cancer, prophylactic treatment, and treatment of infection in the urinary tract- The composition elutes nitric oxide (NO) in a therapeutic dose.

USPTO Abstract

A composition is provided that allows for treatment of cancer, prophylactic treatment, and treatment of infection in the urinary tract- The composition elutes nitric oxide (NO) in a therapeutic dose.

Drugs covered by this patent

Patent Metadata

Patent number
EP1790335A1
Jurisdiction
EP
Classification
—
Expires
2007-05-30
Drug substance claim
No
Drug product claim
No
Assignee
Nolabs AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.